Nippon Express (Nederland) Acquires GDP Compliance Certification for Company-owned Warehouse
{window.open('https://sns.qzone.qq.com/cgi-bin/qzshare/cgi_qzshare_onekey?url='+encodeURIComponent(location.href)+'&title='+encodeURIComponent(document.title)+'&summary=&desc=&pics=https://static.prnasia.com/pro/pcom/includes/images/logo-prn-02_PRN.png','_blank','width=650,height=450');})()){kind=link}
TOKYO, Dec. 8, 2021 /PRNewswire/ -- Nippon Express (Nederland) B.V. (hereinafter "NEN"), a local subsidiary of Nippon Express Co., Ltd., obtained Good Distribution Practice (GDP) certification, effective September 6, for its company-owned warehouse in Schiphol Trade Park near Amsterdam's Schiphol Airport, evidencing its compliance with GDP standards for the proper distribution of pharmaceuticals.
Logo: https://kyodonewsprwire.jp/img/202112014248-O2-DvOj4uIB
Photo1: Warehouse exterior
https://kyodonewsprwire.jp/prwfile/release/M103866/202112014248/_prw_PI1fl_Lv4vEAOc.jpg
Photo2: Warehouse interior
https://kyodonewsprwire.jp/prwfile/release/M103866/202112014248/_prw_PI3fl_78SFb5Xi.jpg
The Netherlands has become home to one of Europe's largest clusters of cutting-edge biotechnology companies, and the country's geographical and tax advantages have encouraged numerous pharmaceutical manufacturers to set up logistics bases there.
NEN's warehouse near Schiphol Airport, an import/export gateway for Europe, is fully equipped with dedicated pharmaceutical storage areas boasting temperature-control functions for three temperature ranges -- 15 C to 25 C (constant-temperature storage), 2 C to 8 C (refrigerated storage) and -15 C to -25 C (frozen storage) -- as well as dedicated truck docks, enabling NEN to enhance its pharmaceutical transport services to meet anticipated increases in demand.
Nippon Express remains committed to improving its services to meet the increasingly sophisticated and diversified pharmaceutical transport needs of its customers, and the Company will continue to strengthen its efforts on behalf of the pharmaceutical industry, identified as a priority industry in its Medium-term Business Plan.
Profile of facility
Name: Nippon Express (Nederland) B.V. Schiphol Airport Logistics Centre
Address: Contour Avenue 31, 2133 LD Hoofddorp, The Netherlands
Nippon Express website: http://www.nipponexpress.com/
Official LinkedIn account: NIPPON EXPRESS GROUP
https://www.linkedin.com/company/nippon-express-group/
View original content:https://www.prnewswire.com/news-releases/nippon-express-nederland-acquires-gdp-compliance-certification-for-company-owned-warehouse-301439789.html
Featured Video
Recent Releases
- Shohei Ohtani Appointed as ITO EN's "Oi Ocha" Global Ambassador to Promote Japan's Tea Culture Worldwide; Ohtani: "Everyday, There's a Green Tea That Stands by My Side"
- OMRON Healthcare's Presence at Heart Rhythm 2024 in the U.S.
- IIJ's "Safous" Zero Trust Access Wins 2024 Cybersecurity Excellence Award for Best Zero Trust Solution
- Animal Quarantine Service Uncovers Foreign National Attempting to Bring Livestock Products into Japan Illegally
- Polyplastics Launches DURAFIDE (R) PPS 1140HS6 -- New Glass-filled PPS Grade with Improved Thermal Shock Resistance
- NX China and NX Automotive Logistics (China) Hold Tree-planting Activity in Guangdong Province
- Go to MediaRoom
Biotechnology Recent Releases
- Duoning Collaborates with Bioelectronica to Commercialize a Single-Cell Sorting System for Antibody Discovery
- HaemaLogiX welcomes former Australian Federal Minister for Health Professor the Hon Greg Hunt to the company board as Non-Executive Director
- TREEFROG PRESENTS DATA FROM THEIR PARKINSON'S DISEASE CELL THERAPY PROGRAM AT THE 29TH WORLD CONGRESS ON PARKINSON'S DISEASE AND RELATED DISORDERS (IAPRD) IN LISBON
- GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Approval
- Innovent Announces Oral Presentations at ESMO Plenary and ESMO GI Congress on Clinical Data of IBI363 (PD-1/IL-2) and IBI343 (CLDN18.2 ADC)
- Read more
Health Care/Hospital Recent Releases
- Pierre Fabre Laboratories announces the submission by Atara Biotherapeutics of Tabelecleucel (Tab-cel®) Biologics License Application for treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S FDA
- Lunit Achieves Historic Milestone: 100 Peer-Reviewed Papers Published on Its AI Medical Imaging Suite
- Duoning Collaborates with Bioelectronica to Commercialize a Single-Cell Sorting System for Antibody Discovery
- HaemaLogiX welcomes former Australian Federal Minister for Health Professor the Hon Greg Hunt to the company board as Non-Executive Director
- TREEFROG PRESENTS DATA FROM THEIR PARKINSON'S DISEASE CELL THERAPY PROGRAM AT THE 29TH WORLD CONGRESS ON PARKINSON'S DISEASE AND RELATED DISORDERS (IAPRD) IN LISBON
- Read more
Medical/Pharmaceuticals Recent Releases
- Pierre Fabre Laboratories announces the submission by Atara Biotherapeutics of Tabelecleucel (Tab-cel®) Biologics License Application for treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S FDA
- Lunit Achieves Historic Milestone: 100 Peer-Reviewed Papers Published on Its AI Medical Imaging Suite
- Duoning Collaborates with Bioelectronica to Commercialize a Single-Cell Sorting System for Antibody Discovery
- HaemaLogiX welcomes former Australian Federal Minister for Health Professor the Hon Greg Hunt to the company board as Non-Executive Director
- TREEFROG PRESENTS DATA FROM THEIR PARKINSON'S DISEASE CELL THERAPY PROGRAM AT THE 29TH WORLD CONGRESS ON PARKINSON'S DISEASE AND RELATED DISORDERS (IAPRD) IN LISBON
- Read more
Pharmaceuticals Recent Releases
- HaemaLogiX welcomes former Australian Federal Minister for Health Professor the Hon Greg Hunt to the company board as Non-Executive Director
- GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Approval
- Innovent Announces Oral Presentations at ESMO Plenary and ESMO GI Congress on Clinical Data of IBI363 (PD-1/IL-2) and IBI343 (CLDN18.2 ADC)
- Qilian International plans to adjust industrial investment
- LiveSpo Pharma Emerges as Vietnam's Pioneer at Vitafoods Europe 2024, Unveiling Groundbreaking Research and Product Development to Reduce Antibiotic Use in Digestive and Respiratory Care
- Read more